MedPath

Early Mobilization in Ventilated SEpsis & Acute Respiratory Failure Study

Not Applicable
Completed
Conditions
Critically Ill
Early Mobility
Interventions
Other: early mobilization
Registration Number
NCT04582760
Lead Sponsor
Samsung Medical Center
Brief Summary

Early mobilization in Ventilated sEpsis \& acute Respiratory failure Study: EVER Study

Detailed Description

This is a multicenter, randomized, assessor-blinded study aiming to investigate the clinical effects of early mobilization in the ICU versus only conventional intensive care for improving physical function after ICU discharge, and after hospital discharge, in patients undergoing mechanical ventilation for acute respiratory failure or sepsis.

Recently, several studies on rehabilitation treatment for patients in intensive care have reported that rehabilitation treatment is safe for patients with ventilators, elderly patients, and patients receiving continuous renal replacement therapy (CRRT) or extracorporeal membrane oxygenation (ECMO). In the United States and Europe, evidence of the stability and clinical outcomes of physical and occupational rehabilitation in the ICU have already been established. In contrast, there is a lack of cost analysis and health and sociological grounds for intensive care rehabilitation in Korea. Therefore, there is an urgent need to evaluate the clinical effects of early rehabilitation, starting on the very first day in the ICU, in patients with acute respiratory failure and sepsis, requiring mechanical ventilation.

The clinical study plan of the current study is as follows. In ICU patients undergoing mechanical ventilation for acute respiratory failure or sepsis, the clinical effects of early mobilization on improving physical function will be assessed using FSS-ICU at discharge from the ICU and discharge from the hospital, and compared to those who did not receive early mobilization.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

You can participate in this clinical trial only if you meet all of the following criteria within 48 hours of ICU hospitalization.

  • Those who voluntarily consent to participate in this clinical trial
  • Those who are over the age of 18 years
  • Patients who require mechanical ventilation for acute respiratory failure and sepsis (non-malignant tumor patients; excluding non-invasive mechanical ventilation and high-flow oxygen therapy)
  • Patients with a Clinical Frailty Scale score of 1-4 points (physical condition prior to entering the ICU)
  • Patients whose mechanical ventilation treatment is expected to last for more than 48 hours (evaluated at the time of study enrollment). However, if the patient has already begun mechanical ventilation treatment at another hospital, the time of airway intubation serves as the reference point. If it is difficult to confirm the exact time, the time of hospitalization is used as the reference point.
Exclusion Criteria
  • Patients with brain damage, psychiatric illness, or cognitive impairment making evaluation difficult
  • Patients who are contraindicated for mobilization (active bleeding, deep vein thrombosis, increased brain pressure, open abdomen, iliac fracture, etc.
  • Patients who do not meet the screening criteria for mobilization (however, if the ICU rehabilitation multidisciplinary team determines that mobilization can be started even if the patient does not meet the screening criteria below, the patient can be included in the study) A. Patients with a Richmond Agitation Sedation Scale (RASS) score less than -2 or greater than +2 B. Patients who have at least one of PEEP ≥ 10cmH2O, FiO2 ≥ 0.6, SpO2 < 90%, respiratory rate ≥ 35/min C. Patients who have at least one of systolic blood pressure <90 mmHg or> 200 mmHg, average arterial pressure> 110 mmHg or <65 mmHg, pulse rate> 130/min or <60/min or newly developed arrhythmia, or currently increasing the dose of inotropic agents.
  • Patients who are pregnant
  • Prisoners
  • Patients with limitations in treatments (e.g., a declaration relating to life-sustaining treatment; or, if the patient is expected to die during hospitalization, if life-sustaining treatment is expected to be discontinued, or if the investigator expects a high probability of mortality (>50%))
  • Patients who have already undergone mechanical ventilation treatment for more than 72 hours (if the patient is re-intubated within 36 hours after airway intubation, the treatment time is calculated as the continued mechanical ventilation time. If the total mechanical ventilation time is within 72 hours, the patient can be registered for the study)
  • Patients who take neuromuscular blockers
  • Patients whose physical function is impaired due to brain or spinal cord diseases
  • Patients who weigh over 100kg
  • Patients who maintain airway intubation and mechanical ventilation only to maintain airway hygiene
  • Post-cardiac pulmonary resuscitation patients
  • Those who are unsuitable for participation in the clinical trial due to other reasons including the results of clinical laboratory tests, according to the judgment of one of the investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
early mobilization Armearly mobilizationIn addition to conventional bedside physical therapy, the mobilization program will be administered for 30 mins per session, two sessions per day, 7 days per week, until the patients are discharged from the ICU.
Primary Outcome Measures
NameTimeMethod
FSS-ICUWithin 24 hours of ICU discharge

Functional Status Score for the Intensive Care Unit Each task is evaluated using an eight-point ordinal scale ranging from 0 (unable to perform) to 7 (complete independence).The total score ranges from 0-35, with higher scores indicating better physical functioning.

Secondary Outcome Measures
NameTimeMethod
Delirium-free durationWithin 24 hours of ICU discharge

Delirium-free duration (28-day delirium-free days)

Length of hospital stayWihin 1 month of hospital discharge

duration of hospitalization

FSS-ICUWihin 24 hours of hospital discharge

Functional Status Score for Intensive Care Unit(FSS-ICU)

Use of Health Care Services1 year after discharged from the hospital

Differences in the Use of Health Care Services

Handgrip dynamometryWihin 24 hours of ICU discharge and hospital discharge

Handgrip dynamometry

TUGWihin 24 hours of hospital discharge

Timed Up and Go Test (TUG)

30s CSSWihin 24 hours of hospital discharge

30s chair sit and stand (30s CSS)

CPAx-respiratory functionWihin 24 hours of ICU discharge and hospital discharge

The Chelsea Critical Care Physical Assessment Tool Respiratory function: Level 0-5 Level 0, complete ventilator dependence. Mandatory breaths only. May be fully sedated/paralised; Level 1, Ventilator dependence. Mandatory breaths with some spontaneous effort; Level 2, Spontaneously breathing with continuous invasive or non-invasive ventilatory support; Level 3, Spontaneouslu breathing with intermittent invasive or non-invasive ventilatory support or continuous high flow oxygen (\>15L);Level 4, Receiving standard oxygen therapy (\<15L);Level 5, Self-ventilating with no oxygen therapy

Health Care Costs1 year after discharged from the hospital

Comparison of Health Care Costs

Mechanical ventilation treatmentWithin 24 hours of ICU discharge

Duration of mechanical ventilation treatment (28-day ventilator-free days)

MRC sum scoreWihin 24 hours of ICU discharge and hospital discharge

Medical Research Council sum score (0-60;0-23,severe muscle weakness;24-35,moderate;36-47,mild)

Length of ICU stayWithin 1 month of ICU discharge

duration of hospitalization in ICU

PICS surveys1 month, 3 months, 6 months, 12 months of hospital discharge

Post Intensive Care Syndrome(PICS) surveys

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath